DR. FARSHID MIRZAEE MD NPI 1194969436

NPI Details

DR. Farshid Mirzaee, MD is an urology in Rancho Mirage, CA with 17 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Farshid Mirzaee, MD NPI is 1194969436. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE
Graduation Year:2009

The provider's business location address is:

39000 BOB HOPE DRIVE PROBST 303
RANCHO MIRAGE, CA
ZIP 92270
Phone: (760) 346-1133

The NPI 1194969436 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Simple change of bladder tube (HCPCS:51705)
• Biopsy of prostate gland (HCPCS:55700)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Complete laser fragmentation of prostate including control of bleeding using an endoscope (HCPCS:52649)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic (HCPCS:G2012)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 4/30/2009 and was last updated on 10/18/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: